Grufity logoGrufity logo
Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest AlphaCentric Advisors LLC Stock Portfolio

$135Million– No. of Holdings #212

AlphaCentric Advisors LLC Performance:
2024 Q2: -6.74%YTD: -7.87%2023: -4.36%
Performance for 2024 Q2 is -6.74%, and YTD is -7.87%, and 2023 is -4.36%.

About AlphaCentric Advisors LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, AlphaCentric Advisors LLC reported an equity portfolio of $135.8 Millions as of 30 Jun, 2024.

The top stock holdings of AlphaCentric Advisors LLC are UTHR, BCRX, RITM. The fund has invested 3.4% of it's portfolio in UNITED THERAPEUTICS CORP DEL and 3.1% of portfolio in BIOCRYST PHARMACEUTICALS INC.

The fund managers got completely rid off UROGEN PHARMA LTD (URGN), CORCEPT THERAPEUTICS INC (CORT) and PERSPECTIVE THERAPEUTICS INC stocks. They significantly reduced their stock positions in KALVISTA PHARMACEUTICALS INC (KALV), CARDINAL HEALTH INC (CAH) and INARI MED INC (NARI). AlphaCentric Advisors LLC opened new stock positions in AMPHASTAR PHARMACEUTICALS IN (AMPH), ENOVIS CORPORATION (ENOV) and PERSPECTIVE THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to SAREPTA THERAPEUTICS INC (SRPT), NVIDIA CORPORATION (NVDA) and INVESCO QQQ TR (QQQ).
AlphaCentric Advisors LLC Equity Portfolio Value
Last Reported on: 25 Jul, 2024

AlphaCentric Advisors LLC Annual Return Estimates Vs S&P 500

Our best estimate is that AlphaCentric Advisors LLC made a return of -6.74% in the last quarter. In trailing 12 months, it's portfolio return was -9.41%.

New Buys

Ticker$ Bought
amphastar pharmaceuticals in1,000,000
enovis corporation904,000
perspective therapeutics inc817,540
amphenol corp new190,792
cintas corp189,770
tjx cos inc new189,592
brown & brown inc183,201
t-mobile us inc181,289
New stocks bought by AlphaCentric Advisors LLC

Additions

Ticker% Inc.
sarepta therapeutics inc2,688
nvidia corporation783
invesco qqq tr188
invesco exch traded fd tr ii188
synchrony financial153
kinross gold corp143
acadia pharmaceuticals inc122
viridian therapeutics inc108
Additions to existing portfolio by AlphaCentric Advisors LLC

Reductions

Ticker% Reduced
kalvista pharmaceuticals inc-98.08
cardinal health inc-85.15
inari med inc-76.19
mercadolibre inc-72.73
mgm resorts international-70.18
ishares tr-68.15
invesco exchange traded fd t-67.95
two harbors inventment corpo-62.4
AlphaCentric Advisors LLC reduced stake in above stock

Sold off

Ticker$ Sold
perspective therapeutics inc-2,090,540
ag mtg invt tr inc-497,468
asensus surgical inc-57,500
intuitive machines inc-937,500
urogen pharma ltd-2,158,470
nano dimension ltd-278,500
corcept therapeutics inc-2,141,150
deciphera pharmaceuticals in-943,800
AlphaCentric Advisors LLC got rid off the above stocks

Sector Distribution

AlphaCentric Advisors LLC has about 49.8% of it's holdings in Healthcare sector.

Sector%
Healthcare49.8
Others23.2
Real Estate13.3
Financial Services5.2
Industrials3.4
Technology2.7
Consumer Cyclical1.1

Market Cap. Distribution

AlphaCentric Advisors LLC has about 24.8% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
UNALLOCATED23.2
SMALL-CAP22
LARGE-CAP21.6
MID-CAP20.8
MICRO-CAP8.6
MEGA-CAP3.2

Stocks belong to which Index?

About 51.8% of the stocks held by AlphaCentric Advisors LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others48.2
RUSSELL 200038.6
S&P 50013.2
Top 5 Winners (%)%
CIM
chimera invt corp
57.6 %
UTHR
united therapeutics corp del
36.6 %
PRCT
procept biorobotics corp
24.5 %
MIRM
mirum pharmaceuticals inc
24.3 %
DYN
dyne therapeutics inc
24.3 %
Top 5 Winners ($)$
UTHR
united therapeutics corp del
1.3 M
BCRX
biocryst pharmaceuticals inc
0.7 M
MIRM
mirum pharmaceuticals inc
0.6 M
PRCT
procept biorobotics corp
0.3 M
AVAV
aerovironment inc
0.2 M
Top 5 Losers (%)%
NVDA
nvidia corporation
-84.2 %
VTYX
ventyx biosciences inc
-58.0 %
CABA
cabaletta bio inc
-55.0 %
RVNC
revance therapeutics inc
-47.8 %
APH
amphenol corp new
-44.1 %
Top 5 Losers ($)$
NVDA
nvidia corporation
-4.0 M
EXAS
exact sciences corp
-0.8 M
KPTI
karyopharm therapeutics inc
-0.7 M
CHRS
coherus biosciences inc
-0.7 M
CABA
cabaletta bio inc
-0.6 M

AlphaCentric Advisors LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of AlphaCentric Advisors LLC

AlphaCentric Advisors LLC has 212 stocks in it's portfolio. About 25.5% of the portfolio is in top 10 stocks. NVDA proved to be the most loss making stock for the portfolio. UTHR was the most profitable stock for AlphaCentric Advisors LLC last quarter.

Last Reported on: 25 Jul, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions